Vnitr Lek 2010, 56(5):392-396

The progress of autonomic parameters in patients after myocardial infarction with ST elevation

P. Lokaj1,*, J. Pařenica1, P. Kala1, N. Honzíková2, R. Lábrová1, J. ©pinar1
1 Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviątě Bohunice, přednosta prof. MUDr. Jindřich ©pinar, CSc., FESC
2 Fyziologický ústav Lékařské fakulty MU Brno, přednostka prof. MUDr. Nataąa Honzíková, CSc.

The patients after myocardial infarction with ST elevation (STEMI) are endangered by the development inception of autonomic dysfunction, decreased baroreflex sensitivity, decreased heart rate variability, and increased blood pressure variability as a result of increased sympathetic activity and/or decreased parasympathetic activity. Thanks to direct angioplasty and optimal pharmacotherapy of coronary artery disease and heart failure, we didn't found any significant changes of these parameters within a one-year follow-up, and mortality due to cardiac etiology was very low in this group. Autonomic dysfunction and negative left ventricular remodeling is related only to a small group of patients after STEMI, whose risk stratification will be difficult.

Keywords: myocardial infarction with ST elevation; baroreflex sensitivity; autonomic dysfunction

Received: February 10, 2010; Accepted: April 1, 2010; Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lokaj P, Pařenica J, Kala P, Honzíková N, Lábrová R, ©pinar J. The progress of autonomic parameters in patients after myocardial infarction with ST elevation. Vnitr Lek. 2010;56(5):392-396.
Download citation

References

  1. Kala P, Poloczek M, Výtiska M et al. Remodelace levé komory po STEMI přední stěny a její vztah k akutním změnám v průběhu primární PCI. Interv Akut Kardiol 2007; 6: 92-96.
  2. La Rovere MT, Specchia G, Mortara A et al. Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with first myocardial infarction. Circulation 1998; 78: 816-824. Go to original source... Go to PubMed...
  3. La Rovere MT, Digger JT Jr, Marcus FI et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Lancet 1998; 351: 478-484. Go to original source... Go to PubMed...
  4. Honzíková N, Semrád B, Fiąer B et al. Risk stratification after myocardial infarction. Scripta Medica 1997; 70: 153-158.
  5. Honzíková N, Semrád B, Fiąer B et al. Baroreflex sensitivity determined by spectral method and heart rate variability, and two-years mortality in patients after myocardial infarction. Physiol Res 2000; 49: 643-650.
  6. Semrád B, Fiąer B, Honzíková N. Baroreflex sensitivity: Do We Have Any Progress? Card Electrophysiol Rev 1999; 3: 290-293. Go to original source...
  7. Zijlstra F, Patel A, Jones M et al. Clinical characteristics and outcome of patients with early (< 2 h), intermediate (2-4 h) and late (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23: 550-557. Go to original source... Go to PubMed...
  8. Brodie BR, Stuckey TD, Wall TC et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 32: 1312-1319. Go to original source... Go to PubMed...
  9. Lantelme P, Cerutti C, Lo M et al. Mechanism of spontaneous baroreflex impairment in Lyon hypertensive rats. Am J Physiol 1998; 275: R920-R925. Go to original source... Go to PubMed...
  10. La Rovere MT, Mortara A, Specchia G et al. Myocardial infarction and baroreflex sensitivity. G Ital Cardiol 1992; 22: 639-645. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.